Basilea to launch Zevtera(r)/Mabelio(r) (ceftobiprole medocaril) in Europe through a commercial services provider. Basilea Pharmaceutica Ltd. (SIX: BSLN) reports that...
Read moreSTALLERGENES (Paris:GENP), a global healthcare company specialized in the diagnosis and treatment of allergies through allergen immunotherapy-based solutions, announced today...
Read moreCTI BioPharma Corp. (CTI) announced today that it has received approval from the Israeli Ministry of Health (MOH) for PIXUVRI®...
Read moreAIDS can be brought under control by 2030, according to a report by the United Nations Aids agency. It said...
Read moreAIDS can be brought under control by 2030, according to a report by the United Nations Aids agency. It said the...
Read moreAbbVie has now laid on the table a bid of £53.20 a share to acquire UK-headquartered Shire, up from last...
Read moreThe business to be sold operates in Europe, Japan, Canada, Australia and New Zealand and includes approximately 3,800 employees Abbott...
Read moreTelmisartan is Glenmark’s generic version of Boehringer Ingelheim’s Micardis Glenmark Generics Inc., US a subsidiary of Glenmark Generics Limited...
Read moreSince the introduction of routine rotavirus vaccination in 2006, rates of diarrhea-related hospitalizations in US children have decreased significantly. ...
Read moreOffers new treatment option for genotype 1 HCV patients in Japan who are interferon-ineligible/intolerant, or did not previously respond to...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.